" class="no-js "lang="en-US"> Biopharma Archives - Medtech Alert
Friday, June 09, 2023

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease

HanAll Biopharma and Daewoong Pharmaceutical announced that they have entered into a co-development agreement with NurrOn […]

CPC Launches Biopharma's Largest Aseptic Connectors, AseptiQuik W Series

CPC (Colder Products Company), part of Dover and a leading manufacturer of connection technologies used […]

PharmaVentures Establishes an Office in Seoul to Enhance Access for South Korean Biotechs

PharmaVentures announces its new office in South Korea as part of its continued strategic expansion. […]

Neochromosome and Sumitovant Biopharma Announce Successful Collaboration to Accelerate Protein Drug Discovery and Improve Manufacturing

Neochromosome, a wholly owned subsidiary of Opentrons Labworks, focused on changing the world of biologics […]

Asieris Appoints Dr. Linda Wu as Chief Development Officer

Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for […]

BioSpace Names Most Promising New Biopharma Companies to Watch in 2023

BioSpace, the leading life sciences news and careers site, has announced its 2023 selections for […]

  1. Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Read more
  2. Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Read more
  3. Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Read more
  4. Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Read more
  5. Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 Read more